Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available
Simple actions can support recovery
Clinical implications of vitamin B12 as redox-active cofactor
Watch for cloudiness, visible particles or precipitate, a color shift (most peptides are colorless GHK-Cu is the exception and reads blue, which is normal), or foam that will not settle
Information provided is educational and not a substitute for medical advice
Of the 12 patients who received only BPC 157, 91.6% reported significant improvement in knee pain, suggesting BPC 157 may help relieve multiple types of knee pain